Prohibitin is required for ras-induced raf–mek–erk activation and epithelial cell migration

Prohibitin is required for ras-induced raf–mek–erk activation and epithelial cell migration

Play all audios:

Loading...

ABSTRACT Ras proteins control the signalling pathways that are responsible for normal growth and malignant transformation1. Raf protein kinases are direct Ras effector proteins that initiate


the mitogen-activated protein kinase (MAPK) cascade2, which mediates diverse biological functions such as cell growth, survival and differentiation3. Here we show that prohibitin, a


ubiquitously expressed and evolutionarily conserved protein4 is indispensable for the activation of the Raf–MEK–ERK pathway by Ras. The membrane targeting and activation of C-Raf by Ras


needs prohibitin in vivo. In addition, direct interaction with prohibitin is required for C-Raf activation. C-Raf kinase fails to interact with the active Ras induced by epidermal growth


factor in the absence of prohibitin. Moreover, in prohibitin-deficient cells the adhesion complex proteins cadherin and β-catenin relocalize to the plasma membrane and thereby stabilize


adherens junctions. Our data show an unexpected role of prohibitin in the activation of the Ras–Raf signalling pathway and in modulating epithelial cell adhesion and migration. Access


through your institution Buy or subscribe This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal


Receive 12 print issues and online access $209.00 per year only $17.42 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices


may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support


SIMILAR CONTENT BEING VIEWED BY OTHERS RAS SUPPRESSION POTENTIATES REAR ACTOMYOSIN CONTRACTILITY-DRIVEN CELL POLARIZATION AND MIGRATION Article 01 July 2024 AFADIN COUPLES RAS GTPASES TO THE


POLARITY RHEOSTAT SCRIBBLE Article Open access 05 August 2022 ACTIVE R-RAS2/TC21 PREVENTS CELL CYCLE ARREST AND MORPHOLOGICAL ALTERATIONS IN MOUSE EMBRYONIC FIBROBLASTS LACKING RAS PROTEINS


Article Open access 31 March 2025 ACCESSION CODES ACCESSIONS BINDPLUS * 312506 * 312507 * 312508 * 312509 REFERENCES * Downward, J. Targeting RAS signalling pathways in cancer therapy.


_Nature Rev. Cancer_ 3, 11–22 (2003). Article  CAS  Google Scholar  * Kyriakis, J. M. et al. Raf-1 activates MAP kinase-kinase. _Nature_ 358, 417–421 (1992). Article  CAS  Google Scholar  *


Wellbrock, C., Karasarides, M. & Marais, R. The RAF proteins take centre stage. _Nature Rev. Mol. Cell Biol._ 5, 875–885 (2004). Article  CAS  Google Scholar  * McClung, J. K., Jupe, E.


R., Liu, X. T. & Dell'Orco, R. T. Prohibitin: potential role in senescence, development, and tumor suppression. _Exp. Gerontol._ 30, 99–124 (1995). Article  CAS  Google Scholar  *


Machuy, N. et al. A global approach combining proteome analysis and phenotypic screening with RNA interference yields novel apoptosis regulators. _Mol. Cell Proteomics_ 4, 44–55 (2004).


Article  Google Scholar  * Harari, D. & Yarden, Y. Molecular mechanisms underlying ErbB2/HER2 action in breast cancer. _Oncogene_ 19, 6102–6114 (2000). Article  CAS  Google Scholar  *


Gschwind, A., Fischer, O. M. & Ullrich, A. The discovery of receptor tyrosine kinases: targets for cancer therapy. _Nature Rev. Cancer_ 4, 361–370 (2004). Article  CAS  Google Scholar  *


Spencer, K. S., Graus-Porta, D., Leng, J., Hynes, N. E. & Klemke, R. L. ErbB2 is necessary for induction of carcinoma cell invasion by ErbB family receptor tyrosine kinases. _J. Cell


Biol._ 148, 385–397 (2000). Article  CAS  Google Scholar  * Klemke, R. L. et al. Regulation of cell motility by mitogen-activated protein kinase. _J. Cell Biol._ 137, 481–492 (1997). Article


  CAS  Google Scholar  * Dhillon, A. S., Meikle, S., Yazici, Z., Eulitz, M. & Kolch, W. Regulation of Raf-1 activation and signalling by dephosphorylation. _EMBO J._ 21, 64–71 (2002).


Article  CAS  Google Scholar  * Kolch, W. et al. Protein kinase Cα activates RAF-1 by direct phosphorylation. _Nature_ 364, 249–252 (1993). Article  CAS  Google Scholar  * Bruder, J. T.,


Heidecker, G. & Rapp, U. R. Serum-, TPA-, and Ras-induced expression from Ap-1/Ets-driven promoters requires Raf-1 kinase. _Genes Dev._ 6, 545–556 (1992). Article  CAS  Google Scholar  *


Hekman, M. et al. Associations of B- and C-Raf with cholesterol, phosphatidylserine, and lipid second messengers: preferential binding of Raf to artificial lipid rafts. _J. Biol. Chem._


277, 24090–24102 (2002). Article  CAS  Google Scholar  * Hekman, M. et al. Dynamic changes in C-Raf phosphorylation and 14–3-3 protein binding in response to growth factor stimulation:


differential roles of 14–3-3 protein binding sites. _J. Biol. Chem._ 279, 14074–14086 (2004). Article  CAS  Google Scholar  * Mineo, C., James, G. L., Smart, E. J. & Anderson, R. G.


Localization of epidermal growth factor-stimulated Ras/Raf-1 interaction to caveolae membrane. _J. Biol. Chem._ 271, 11930–11935 (1996). Article  CAS  Google Scholar  * Wang, S., Nath, N.,


Fusaro, G. & Chellappan, S. Rb and prohibitin target distinct regions of E2F1 for repression and respond to different upstream signals. _Mol. Cell Biol._ 19, 7447–7460 (1999). Article 


CAS  Google Scholar  * Kolonin, M. G., Saha, P. K., Chan, L., Pasqualini, R. & Arap, W. Reversal of obesity by targeted ablation of adipose tissue. _Nature Med._ 10, 625–632 (2004).


Article  CAS  Google Scholar  * Shields, J. M., Pruitt, K., McFall, A., Shaub, A. & Der, C. J. Understanding Ras: 'it ain't over 'til it's over'. _Trends Cell


Biol._ 10, 147–154 (2000). Article  CAS  Google Scholar  * Kerkhoff, E. & Rapp, U. R. The Ras-Raf relationship: an unfinished puzzle. _Adv. Enzyme Regul._ 41, 261–267 (2001). Article 


CAS  Google Scholar  * Avruch, J. et al. Ras activation of the Raf kinase: tyrosine kinase recruitment of the MAP kinase cascade. _Recent Prog. Horm. Res._ 56, 127–155 (2001). Article  CAS 


Google Scholar  * Light, Y., Paterson, H. & Marais, R. 14–3-3 antagonizes Ras-mediated Raf-1 recruitment to the plasma membrane to maintain signaling fidelity. _Mol. Cell Biol._ 22,


4984–4996 (2002). Article  CAS  Google Scholar  * Dumaz, N. & Marais, R. Protein kinase A blocks Raf-1 activity by stimulating 14–3-3 binding and blocking Raf-1 interaction with Ras. _J.


Biol. Chem._ 278, 29819–29823 (2003). Article  CAS  Google Scholar  * Kubicek, M. et al. Dephosphorylation of Ser-259 regulates Raf-1 membrane association. _J. Biol. Chem._ 277, 7913–7919


(2002). Article  CAS  Google Scholar  * Ory, S., Zhou, M., Conrads, T. P., Veenstra, T. D. & Morrison, D. K. Protein phosphatase 2A positively regulates Ras signaling by


dephosphorylating KSR1 and Raf-1 on critical 14–3-3 binding sites. _Curr. Biol._ 13, 1356–1364 (2003). Article  CAS  Google Scholar  * Sharma, A. & Qadri, A. Vi polysaccharide of


_Salmonella typhi_ targets the prohibitin family of molecules in intestinal epithelial cells and suppresses early inflammatory responses. _Proc. Natl Acad. Sci. USA_ 101, 17492–17497 (2004).


Article  CAS  Google Scholar  * Hirohashi, S. & Kanai, Y. Cell adhesion system and human cancer morphogenesis. _Cancer Sci._ 94, 575–581 (2003). Article  CAS  Google Scholar  * Wang, K.


J., Wang, R. T. & Zhang, J. Z. Identification of tumor markers using two-dimensional electrophoresis in gastric carcinoma. _World J. Gastroenterol._ 10, 2179–2183 (2004). Article  CAS 


Google Scholar  * Srisomsap, C. et al. Detection of cathepsin B up-regulation in neoplastic thyroid tissues by proteomic analysis. _Proteomics_ 2, 706–712 (2002). Article  CAS  Google


Scholar  * Asamoto, M. & Cohen, S. M. Prohibitin gene is overexpressed but not mutated in rat bladder carcinomas and cell lines. _Cancer Lett._ 83, 201–207 (1994). Article  CAS  Google


Scholar  * Smart, E. J., Ying, Y. S., Conrad, P. A. & Anderson, R. G. Caveolin moves from caveolae to the Golgi apparatus in response to cholesterol oxidation. _J. Cell Biol._ 127,


1185–1197 (1994). Article  CAS  Google Scholar  Download references ACKNOWLEDGEMENTS We thank M. Oswald, D. Khalil, C. Dimmler, B. Fauler and U. Reichard for excellent technical assistance,


T. Fowler for critical reading of the manuscript and the EURIT team for their help with siRNA validation. M. Selbach is thanked for kindly providing the Ras constructs and S. Lohmann for the


VASP-P157 antibodies. This work was supported by grants from the Bundesministerium für Bildung und Forschung (BMBF) to T.R. AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Department of


Molecular Biology, Max Planck Institute for Infection Biology, Schumannstr. 21/22, Berlin, D-10117, Germany Krishnaraj Rajalingam, Christian Wunder, Yuri Churin, Claudia Sievers & Thomas


Rudel * Microscopy Core Facility, Schumannstr. 21/22, Berlin, D-10117, Germany Volker Brinkmann * Institut für Medizinische Strahlenkunde und Zellforschung, University of Würzburg,


Versbacher Strasse 5, Würzburg, 97078, Germany Mirko Hekman & Ulf R. Rapp Authors * Krishnaraj Rajalingam View author publications You can also search for this author inPubMed Google


Scholar * Christian Wunder View author publications You can also search for this author inPubMed Google Scholar * Volker Brinkmann View author publications You can also search for this


author inPubMed Google Scholar * Yuri Churin View author publications You can also search for this author inPubMed Google Scholar * Mirko Hekman View author publications You can also search


for this author inPubMed Google Scholar * Claudia Sievers View author publications You can also search for this author inPubMed Google Scholar * Ulf R. Rapp View author publications You can


also search for this author inPubMed Google Scholar * Thomas Rudel View author publications You can also search for this author inPubMed Google Scholar CORRESPONDING AUTHOR Correspondence to


Thomas Rudel. ETHICS DECLARATIONS COMPETING INTERESTS A patent application has been filed. SUPPLEMENTARY INFORMATION SUPPLEMENTARY INFORMATION Supplementary figures S1, S2, S3 and S4;


supplementary methods and movie legends (PDF 428 kb) SUPPLEMENTARY INFORMATION, MOVIE S1 (AVI 3034 KB) SUPPLEMENTARY INFORMATION, MOVIE S2 (AVI 3018 KB) SUPPLEMENTARY INFORMATION, MOVIE S3


(AVI 2959 KB) SUPPLEMENTARY INFORMATION, MOVIE S4 (AVI 3104 KB) RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Rajalingam, K., Wunder, C., Brinkmann, V.


_et al._ Prohibitin is required for Ras-induced Raf–MEK–ERK activation and epithelial cell migration. _Nat Cell Biol_ 7, 837–843 (2005). https://doi.org/10.1038/ncb1283 Download citation *


Received: 11 May 2005 * Accepted: 28 June 2005 * Published: 24 July 2005 * Issue Date: August 2005 * DOI: https://doi.org/10.1038/ncb1283 SHARE THIS ARTICLE Anyone you share the following


link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature


SharedIt content-sharing initiative